Treatment with recombinant Hsp72 suppresses collagen-induced arthritis in mice

Inflammation

Volumn 34, Issue 5, 2011, Pages 432-439

  Luo, Xinjing ^a,b   Zuo, Xiaoxia ^c   Mo, Xuanrong ^b   Zhou, Yaou ^c   Xiao, Xianzhong ^a  

^a Central South University   (China)

^b TAIZHOU UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Animal models; Arthritis; Cytokines; Heat shock protein; Signal pathways

Indexed keywords

HEAT SHOCK PROTEIN 72; INTERLEUKIN 6; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BONE DESTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVITIS; TREATMENT RESPONSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; FEMALE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICE; MICE, INBRED DBA; NF-KAPPA B; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 80655146272     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9250-z     Document Type: Article

References (41)

1. Georganas, C., H. Liu, H. Perlman, A. Hoffmann, B. Thimma-paya, and R.M. Pope. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: The dominant role for NF-kappa B but not C/EBP beta or c-Jun. Journal of Immunology 165: 7199-7206. (Pubitemid 32001197)
2. Ivashkiv, L.B. 1996. Cytokine expression and cell activation in inflammatory arthritis. Advances in Immunology 63: 337-376. (Pubitemid 26296143)
3. Brennan, F.M., R.N. Maini, and M. Feldmann. 1998. Role ofpro-inflammatory cytokines in rheumatoid arthritis. Springer Semi-nars in Immunopathology 20: 133-147. (Pubitemid 28502453)
4. Wong, PK., I.K. Campbell, PJ. Egan, M. Ernst, and I.P Wicks. 2003. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis and Rheuma-tism 48: 1177-1189. (Pubitemid 36554516)
5. Matsuno, H., K. Yudoh, R. Katayama, F. Nakazawa, M. Uzuki, T Sawai, et al. 2002. The role of TNF-alpha in the pathogenesis of inflammation andjoint destruction in rheumatoid arthritis (RA): A study using a human RA/SCID mouse chimera. Rheumatology (Oxford) 41: 329-337. (Pubitemid 34537871)
6. Nakahara, H., and N. Nishimoto. 2006. Anti-interleukin-6 receptor antibody therapy in rheumatic diseases. Endocrine, Metabolic & Immune Disorders Drug Targets 6: 373-381. (Pubitemid 44941925)
7. Wendling, D., E. Racadot, and J. Wijdenes. 1993. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody The Journal of Rheumatology 20: 259-262. (Pubitemid 23066035)
8. Choy E.H., DA. Isenberg, T Garrood, S. Farrow, Y Ioannou, H. Bird, et al. 2002. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-con trolled, dose-escalation trial. Arthritis and Rheumatism 46: 3143-3150. (Pubitemid 35453522)
9. Gerlag, D.M., L. Ransone, PP Tak, Z. Han, M. Palanki, M.S. Barbosa, et al. 2000. The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. Journal of Immunology 165: 1652-1658. (Pubitemid 30604604)
10. Handel, M.L., L.B. Mc Morrow, and E.M. Gravallese. 1995. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis and Rheumatism 38: 1762-1770.
11. Marok, R., PG. Winyard, A. Coumbe, M.L. Kus, K. Gaffney, S. Blades, et al. 1996. Activation of the transcription factor nuclear factor-kappa B in human inflamed synovial tissue. Arthritis and Rheumatism 39: 583-591. (Pubitemid 26118035)
12. Fujisawa, K., H. Aono, T. Hasunuma, K. Yamamoto, S. Mita, and K. Nishioka. 1996. Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis & Rheumatism 39: 197-203. (Pubitemid 26065259)
13. Roshak, A.K., J.R. Jackson, K. Mc Gough, M. Chabot-Fletcher, E. Mochan, and LA. Marshall. 1996. Manipulation of distinct NF kappa B proteins alters interleukin-1beta-induced human rheuma-toid synovial fibroblast prostaglandin E2 formation. The Journal of Biological Chemistry 271: 31496-31501. (Pubitemid 26408607)
14. Johnson, J.D., and M. Fleshner. 2006. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. Journal of Leukocyte Biology 79: 425-434. (Pubitemid 44831219)
15. Tsan, M.F., and B. Gao. 2004. Cytokine function of heat shock proteins. American Journal of Physiology. Cell Physiology 286: C739-C744. (Pubitemid 38543800)
16. van Eden, W, R. van der Zee, and B. Prakken. 2005. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nature Reviews. Immunology 5: 318-330. (Pubitemid 40516157)
17. Schett, G., K. Redlich, Q. Xu, P. Bizan, M. Groger, M. Tohidast-Akrad, et al. 1998. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation ofhsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. Journal of Clinical Investigation 102: 302-311. (Pubitemid 28335189)
18. Martin, C.A., S.E. Carsons, R. Kowalewski, D. Bernstein, M. Valentino, and F. Santiago-Schwarz. 2003. Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: Possible mechanisms of hsp/ DC-mediated cross-priming. Journal of Immunology 171: 5736-5742. (Pubitemid 37467188)
19. Luo, X., X. Zuo, Y Zhou, B. Zhang, Y Shi, M. Liu, et al. 2008. Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes. Arthritis Research & Therapy 10: R41.
20. Liu, S., R. Tobias, S. Mc Clure, G. Styba, Q. Shi, and G. Jackowski. 1997. Removal of endotoxin from recombinant protein prepara-tions. Clinical Biochemistry30: 455-463. (Pubitemid 27418541)
21. Mould, A.W, I.D. Tonks, M.M. Cahill, A.R. Pettit, R. Thomas, N. K. Hayward, et al. 2003. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis and Rheumatism 48: 2660-2669. (Pubitemid 37129444)
22. Han, Z., D.L. Boyle, A.M. Manning, and G.S. Firestein. 1998. AP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28: 197-208. (Pubitemid 29027651)
23. Panayi, G.S., VM. Corrigall, and B. Henderson. 2004. Stress cytokines: Pivotal proteins in immune regulatory networks; Opinion. Current Opinion in Immunology 16: 531-534. (Pubitemid 38881684)
24. Wendling, U., L. Paul, R. van der Zee, B. Prakken, M. Singh, and W van Eden. 2000. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal admin-istration and induces IL-10-producing Tcells that cross-react with the mammalian self-hsp70 homologue. Journal of Immunology 164: 2711-2717. (Pubitemid 30115504)
25. Prakken, B.J., U. Wendling, R. van der Zee, VP Rutten, W Kuis, and W van Eden. 2001. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. Journal of Immunology 167: 4147-4153. (Pubitemid 32954286)
26. Panayi, G.S., and VM. Corrigall. 2006. Bi P regulates autoimmune inflammation and tissue damage. Autoimmunity Reviews 5: 140-142. (Pubitemid 43129546)
27. Panayi, G.S., and VM. Corrigall. 2008. Bi P, an anti-inflammatory ER protein, is a potential new therapy for the treatment of rheumatoid arthritis. Novartis Foundation Symposium 291: 212-216. discussion 216-224.
28. Panayi, G., and V Corrigall. 2004. Bi P: A new biologic immunomodulator for the treatment of rheumatoid arthritis. Auto-immunity Reviews 3(Suppl 1): S16-S17.
29. Bodman-Smith, M.D., VM. Corrigall, D.M. Kemeny and G.S. Panayi. 2003. Bi P, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals. Rheumatology (Oxford) 42: 637-644. (Pubitemid 37220872)
30. Wong, S.H., and J.M. Lord. 2004. Factors underlying chronic inflammation in rheumatoid arthritis. Archivum Immunologiae et Therapiae Experimentalis (Warsz) 52: 379-388. (Pubitemid 40115972)
31. Hata, H., N. Sakaguchi, H. Yoshitomi, Y Iwakura, K. Sekikawa, Y Azuma, et al. 2004. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to Tcell-mediated spontaneous autoimmune arthritis in mice.Journal of Clinical Investigation 114: 582-588. (Pubitemid 39572108)
32. Zabel, U., T. Henkel, M.S. Silva, and PA. Baeuerle. 1993. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. The EMBO Journal 12: 201-211. (Pubitemid 23042397)
33. Sen, R., and D. Baltimore. 1986. Inducibility of kappa immuno-globulin enhancer-binding protein Nf-kappa B by a posttransla-tional mechanism. Cell 47: 921-928. (Pubitemid 17005065)
34. Neurath, M.F., S. Pettersson, K.H. Meyer zum Buschenfelde, and W Strober. 1996. Local administration of antisense phosphoro-thioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Natural Medicines 2: 998-1004. (Pubitemid 26306838)
35. Baldwin Jr., A.S. 2001. Series introduction: The transcription factor NF-kappa B and human disease. Journal of Clinical Inves-tigation 107: 3-6.
36. Miagkov, A.V, D.V Kovalenko, C.E. Brown, J.R. Didsbury J.P Cogswell, SA. Stimpson, et al. 1998. NF-kappa B activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proceedings of the National Academy of Sciences of the United States of America 95: 13859-13864. (Pubitemid 28523063)
37. Tsao, PW, T Suzuki, R. Totsuka, T Murata, T Takagi, Y Ohmachi, et al. 1997. The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis. Clinical Immunology and Immunopathology 83: 173-178. (Pubitemid 27195937)
38. Vermeulen, L., G. De Wilde, P Van Damme, W Vanden Berghe, and G. Haegeman. 2003. Transcriptional activation of the NF-kappa B p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).EMBOJournal22: 1313-1324. (Pubitemid 36362695)
39. Aneja, R., K. Odoms, K. Dunsmore, T.P Shanley and H.R. Wong. 2006. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. Journal of Immunology 177: 7184-7192. (Pubitemid 44715087)
40. Asea, A., M. Rehli, E. Kabingu, JA. Boch, O. Bare, PE. Auron, et al. 2002. Novel signal transduction pathway utilized by extrac-ellular HSP70: Role oftoll-like receptor (TLR) 2 and TLR4. The Journal of Biological Chemistry 277: 15028-15034. (Pubitemid 34952579)
41. Chase, M.A., D.S. Wheeler, K.M. Lierl, VS. Hughes, H.R. Wong, and K. Page. 2007. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappa B-dependent mechanism. Journal of Immunology 179: 6318-6324.